Glipizide
-
Subject Areas on Research
- Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus.
- Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM.
- Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
- Glipizide stimulates sympathetic outflow in diabetes-prone mice.
- Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
- Long-term safety and efficacy of glipizide.
- Mechanism of action of the second-generation sulfonylurea glipizide.
- Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
- Sulfonylurea treatment of insulin-independent diabetes mellitus.
- Sulphonylureas increase the number of insulin receptors.
- Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.